Psychiatry & Neurology Doctors in Manchester Center, VT Accepting Medicare

1 Psychiatry & Neurology doctors found. Showing 1 - 1

Dr. Robert Jomax Brooks, MD Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 82 Elm St, Manchester Center, VT 05255 Phone: 413-281-8791    Fax: 866-686-8033

News Archive

Preventing lung scarring may extend lives of lung cancer patients

Researchers have found that using a special type of drug called a pharmaceutical monoclonal antibody to block the integrin beta6-TGF-beta pathway prevents a serious side effect of radiation therapy for lung cancer patients – pulmonary fibrosis (scarring of the lungs), thereby extending patients' lives and improving their quality of life, according to a study presented at the Plenary I session on October 29, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.

Experts launch mhNOW initiative to bring proven mental health solutions to people most in need

Today, the Mental Health Now, or mhNOW, initiative will launch at the inaugural Financing and Innovation in Global Health (FIGH) conference. Led by mental health experts Chris Underhill, founder and president of BasicNeeds, and Moitreyee Sinha, head of health at the Global Development Incubator (GDI), mhNOW is a global, collective action including social entrepreneurs, organizations and companies that are working together to innovate and identify mental health solutions on a global scale, and systemically implement in communities at a local level.

High-dose IL-2 still the most effective treatment for patients with stage IV metastatic melanoma

Administering high-doses of interleukin-2 (IL-2) has been the preferred treatment for patients with stage IV metastatic melanoma. An article published in the current issue of Cancer Biotherapy and Radiopharmaceuticals, a peer-reviewed journal from Mary Ann Liebert, Inc., explores whether or not this regimen is still the most effective.

AASLD, EASL to hold special conference on therapy of HCV

The European Association for the Study of the Liver (EASL), together with the American Association for the Study of Liver Diseases (AASLD), will be holding an exciting "Special Conference" dedicated to the timely topic of: Therapy of Hepatitis C: Clinical Application and Drug Development.

Top-line results from Neuraltus' NP001 Phase 2 study on amyotrophic lateral sclerosis

Neuraltus Pharmaceuticals, a private biopharmaceutical company developing novel therapies for rare neurological disorders, announced today top-line results from the Company's Phase 2 clinical study of NP001 in patients with Amyotrophic Lateral Sclerosis (ALS, or Lou Gehrig's disease).

Read more Medical News

› Verified 2 days ago